PAP devices market seen rising to $8.25 billion by 2030

The positive airway pressure devices market is projected to grow from $4.66 billion in 2025 to $5.23 billion in 2026, with North America the largest regional market and Asia-Pacific the fastest-growing. The report points to rising sleep apnea cases, home care demand and connected therapy tools as major growth drivers through 2030.

Why it matters: - Positive airway pressure devices are central to treating obstructive sleep apnea, a disorder tied to daytime fatigue, cardiovascular risk and lower quality of life. - The market’s projected rise signals stronger demand for non-invasive respiratory care, home-based therapy and connected sleep-health tools. - Growth in the category also reflects broader diagnosis and treatment of sleep-related breathing disorders.

What happened: - The Business Research Company published a 2026 market report on positive airway pressure devices. - The report estimates the market will grow from $4.66 billion in 2025 to $5.23 billion in 2026. - The report projects the market will reach $8.25 billion by 2030. - The company said the market is expanding as awareness and diagnosis of sleep-related breathing disorders rise.

The details: - The report pegs 2025-2026 growth at 12.3% CAGR. - The forecast period from 2026 to 2030 implies 12.1% CAGR. - The market’s historical growth has been supported by rising sleep apnea cases, wider access to sleep diagnostic services and more adoption of non-invasive respiratory treatments. - The report says the next phase of growth will be driven by demand for connected home healthcare, long-term respiratory disease management and telemedicine-enabled sleep therapies. - Artificial intelligence for therapy optimization and more tailored treatment options are also listed as growth supports. - The report expects wider use of smart PAP devices with built-in monitoring. - The report also points to growing demand for cloud-connected compliance tracking, compact and travel-friendly designs, and better comfort and noise reduction. - Positive airway pressure devices deliver continuous airflow through a mask to keep the airway open during sleep. - PAP devices are primarily used to treat obstructive sleep apnea and improve respiratory function. - The report says obesity is a major contributor to OSA because excess tissue around the neck can narrow the airway and raise the risk of collapse during sleep. - In May 2025, Oxford Academic research projected that OSA prevalence among older adults will rise sharply by 2050, especially among older women. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America was the largest market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also highlights market attractiveness scoring, total addressable market analysis, company scoring matrix graphics, Excel dashboards, market hotspots infographics, key technologies and future trends, plus updated graphics and tables. - A free sample report is available. - The full market report is available online.

Between the lines: - The forecast suggests the market is moving from specialty sleep therapy toward broader digital, home-based and compliance-tracked care. - North America’s current lead and Asia-Pacific’s faster growth point to an established market in mature health systems and rising demand in expanding ones. - The emphasis on AI, telemedicine and cloud tracking suggests buyers are looking beyond the device itself to ongoing therapy management.

What’s next: - The market is expected to keep growing through 2030 as sleep apnea diagnosis expands and care shifts further into the home. - Product development will likely focus on smarter devices, smaller form factors and easier-to-manage therapy workflows. - Regional growth outside North America, especially in Asia-Pacific, is likely to stay a key watch point for suppliers and investors.